The life of the Rt. Hon. Sir Charles W. Dilke, bart., M.P.,

Mode of access: Internet.

Charles W. Thompson (late a representative from Alabama) Memorial addresses delivered in the House of Representatives and Senate, second session of the Fifty-eighth Congress.

Mode of access: Internet.

Charles W. Eliot, president of Harvard University (May 19, 1869-May 19, 1909)

"This essay was originally written for the Deutsche rundschau of Berlin." - Note.

Sir Charles W. Macara, bart. : a study of modern Lancashire /

Mode of access: Internet.

Interview with Charles W. Peck

Interview in five sessions, October-November 2003, with Charles W. Peck, professor of physics (now emeritus) in the Division of Physics, Mathematics, and Astronomy. He recalls his early life in South Texas and his interest in radio; first year of college at Texas Arts & Industries; three more years at New Mexico College of Agriculture & Mechanical Arts. Recalls graduate studies at Caltech with Murray Gell-Mann, H. P. Robertson, Robert Walker, Richard A. Dean, W. R. Smythe. Works on increasing intensity and stability of the Caltech synchrotron, with Walker, Matt Sands, and Alvin Tollestrup; 1964 thesis on K-lambda photoproduction. Joins the faculty as an assistant professor in 1965. Discusses his various teaching assignments, including an embarrassing moment when Richard Feynman attended one of his freshman physics lectures. Discusses his research at the Stanford Linear Accelerator Center and Lawrence Radiation Laboratory’s Bevatron. Collaboration with UC Berkeley and SLAC on “crystal ball” detector for SLAC’s SPEAR storage ring. Taking the crystal ball to DESY, in Hamburg. Works with Barry Barish at Gran Sasso laboratory in Italy, on MACRO; search for magnetic monopoles. He also discusses his administration work at Caltech, as executive officer for physics (1983-1986) and as PMA division chair from 1993 to 1998, when he immediately had to deal with the troubles plaguing LIGO [Laser Interferometer Gravitational-wave Observatory]. Detailed discussion of the LIGO contretemps and how it was settled, and of turning Big Bear Solar Observatory over to the New Jersey Institute of Technology. Advent of David Baltimore as Caltech president; attempt to recruit Ed Witten.

Charles W. Kotcher 204799

This vessel was built at Lorain, Ohio in 1907 by the American Ship Building Company. Until 1915, she was owned by the Detroit Steamship Company of Detroit, Michigan. From 1915 to 1950, she was owned by the Wilson Transit Company of Cleveland, Ohio. From 1950 to 1968, she was owned by the Gartland Steamship Company of Chicago and the U. S. From 1920 to 1969, she was known as the "Frank E. Taplin." In 1969, she was towed along with the "Howard M. Hanna, Jr." to Cartagena, Spain for scrapping.

Adesp. fr. 700 K.-Sn. y "Andrómeda" de Eurípides

adesp. fr. 700 Kn.-Sn. podría proceder de Andrómeda de Eurípides y no de una Níobe. Los siguientes elementos de los frs. (a) y (b) pueden responder a lo que se conoce de la tragedia de Eurípides: (a) la semejanza con una estatua; (b) la novia de Hades; (c) el silencio del personaje; (d) la colaboración con las Moiras; (e) el contraste entre la fortuna regia y la desgracia y el sufrimiento de los padres. No es, por tanto, necesario modificar el texto recibido para eliminar μάγους πάγας y la referencia a las trampas mágicas en el v. 5, que cuadra bien con Medusa y Perseo.

The life and speeches of Hon. Charles Warren Fairbanks, Republican candidate for vice-president,

Mode of access: Internet.

Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis

The mechanistic details of the pathogenesis of Chlamydia, an obligate intracellular pathogen of global importance, have eluded scientists due to the scarcity of traditional molecular genetic tools to investigate this organism. Here we report a chemical biology strategy that has uncovered the first essential protease for this organism. Identification and application of a unique CtHtrA inhibitor (JO146) to cultures of Chlamydia resulted in a complete loss of viable elementary body formation. JO146 treatment during the replicative phase of development resulted in a loss of Chlamydia cell morphology, diminishing inclusion size, and ultimate loss of inclusions from the host cells. This completely prevented the formation of viable Chlamydia elementary bodies. In addition to its effect on the human C. trachomatis strain, JO146 inhibited the viability of the mouse strain, Chlamydia muridarum, both in vitro and in vivo. Thus, we report a chemical biology approach to establish an essential role for Chlamydia CtHtrA. The function of CtHtrA for Chlamydia appears to be essential for maintenance of cell morphology during replicative the phase and these findings provide proof of concept that proteases can be targetted for anti-microbial therapy for intracellular pathogens.

Proof of concept : A bioinformatic and serological screening method for identifying new peptide antigens for Chlamydia trachomatis related sequelae in women

This study aimed to identify new peptide antigens from Chlamydia (C.) trachomatis in a proof of concept approach which could be used to develop an epitope-based serological diagnostic for C. trachomatis related infertility in women. A bioinformatics analysis was conducted examining several immunodominant proteins from C. trachomatis to identify predicted immunoglobulin epitopes unique to C. trachomatis. A peptide array of these epitopes was screened against participant sera. The participants (all female) were categorized into the following cohorts based on their infection and gynecological history; acute (single treated infection with C. trachomatis), multiple (more than one C. trachomatis infection, all treated), sequelae (PID or tubal infertility with a history of C. trachomatis infection), and infertile (no history of C. trachomatis infection and no detected tubal damage). The bioinformatics strategy identified several promising epitopes. Participants who reacted positively in the peptide 11 ELISA were found to have an increased likelihood of being in the sequelae cohort compared to the infertile cohort with an odds ratio of 16.3 (95% c.i. 1.65 – 160), with 95% specificity and 46% sensitivity (0.19-0.74). The peptide 11 ELISA has the potential to be further developed as a screening tool for use during the early IVF work up and provides proof of concept that there may be further peptide antigens which could be identified using bioinformatics and screening approaches.